SVA
Sinovac Biotech Ltd
6.50$
+0.0%
vs. previous close
Closing price · As of: Sep 12, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q2 22 | Q3 22 | Q1 23 | Q2 23 | Q4 23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +498.5% | +3,312.0% | +0.0% | +1,788.8% | -31.1% | -112.9% | – | -454.6% | – | -74.8% | |
| – | +95.5% | -79.1% | +272.2% | +0.0% | +1,220.7% | +314.4% | +12.9% | +167.2% | -27.0% | -148.2% | – | |
| – | +0.1% | +958.7% | -90.6% | +0.0% | – | – | – | – | – | – | – | |
| – | – | +439.1% | +303.5% | – | – | – | – | – | – | – | – | |
| – | – | -985.1% | – | +0.0% | +78.3% | -115.6% | – | – | – | – | +5,557,920.0% | |
| – | +1,010.4% | -0.4% | +73.6% | +0.0% | +667.1% | -30.8% | -5.9% | -92.9% | +1,208.0% | -94.3% | +245.3% | |
| – | -286.6% | -36.5% | +400.7% | +0.0% | +2,052.4% | – | -1,526.4% | -36.1% | – | – | -92.9% | |
| – | – | – | – | – | – | +8,225.0% | -99.0% | +799.0% | +55.2% | -45.1% | – | |
| – | -100.0% | – | – | – | – | – | +32.6% | -63.2% | – | – | – | |
| – | +204.3% | -19.9% | +3,607.5% | – | – | – | – | – | – | – | – | |
| – | +219.4% | +8.6% | +2,250.0% | +0.0% | -105.5% | +6,122.9% | – | -2,955.7% | +147.6% | -3.1% | -63.4% | |
| – | -290.0% | – | +9,683.8% | +0.0% | +647.2% | -28.9% | -199.8% | – | +3,235.9% | -105.0% | – | |
| – | – | – | – | +0.0% | +1,942.2% | -31.1% | -118.4% | – | -556.1% | – | -83.5% |
Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.